MOL-4239 Uses, Dosage, Side Effects and more
MOL-4239 is under investigation in clinical trial NCT01826201 (Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis).
| Trade Name | MOL-4239 |
| Generic | MOL-4239 |
| Type | |
| Formula | C19H16BrN3O |
| Weight | Average: 382.261 Monoisotopic: 381.047675 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
